MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
37.34
+2.80
+8.11%
After Hours: 37.34 0 0.00% 16:09 06/26 EDT
OPEN
34.44
PREV CLOSE
34.54
HIGH
37.48
LOW
34.23
VOLUME
1.48M
TURNOVER
--
52 WEEK HIGH
37.99
52 WEEK LOW
10.23
MARKET CAP
1.68B
P/E (TTM)
-45.6982
1D
5D
1M
3M
1Y
5Y
1D
Health Care had the best week vs. the S&P 500 on record
Seeking Alpha · 1d ago
Septerna SVP Drug Discovery Daniel D. Long disposes of 15,000 common shares worth $548,782
PUBT · 3d ago
Weekly Report: what happened at SEPN last week (0615-0619)?
Weekly Report · 5d ago
Wells Fargo Keeps Their Buy Rating on Septerna, Inc. (SEPN)
TipRanks · 06/17 10:37
Septerna: A De-Risking GPCR Story With Near-Term Upside Catalysts
Seeking Alpha · 06/17 06:18
Septerna Chief People Officer Samira Shaikhly sells 6,250 shares worth $219,224.38
PUBT · 06/17 00:32
Weekly Report: what happened at SEPN last week (0608-0612)?
Weekly Report · 06/15 09:47
Septerna initiated with a Buy at Guggenheim
TipRanks · 06/11 10:23
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.